Advair HFA Inhaler 与 Ryzolt
Advair HFA Inhaler 与 Ryzolt互相作用以及同时服用的可能性。
在该服务的官方手册中,已注明相关研究结果统计规定的互相作用。该互相作用或对患者健康引起不良后果,或起到良好效果。具体联合用药问题,需遵从医嘱。
用户:使用沙美特罗在一起曲马多可以增加风险的一个不规则的心脏的节奏可能是严重的和潜在威胁生命,尽管它是一个罕见的副作用。 你可以更容易受如果你有一个称为先天性心脏病长期脱综合症,其他心脏疾病,导异常,或电解质紊乱(例如,镁或钾的损失,由于严重或长期腹泻或者呕吐)。 风险可能存在即使在沙美特罗或类似药物都是通过口服吸入直接进入肺部,更是如此,如果这些产品的过度使用。 不超过剂量和使用频率的建议在产品标签,或者规定通过你的医生。 谈谈你的医生如果你有任何疑问或关切的问题。 你的医生可能已经知道的风险,但是已确定这是最好的治疗并采取适当的预防措施和监控你的密切对任何潜在并发症。 你应该立即寻求医疗照顾,如果你开发的突然眩晕、头晕、眩晕、呼吸急促、或心悸在处理与这些药物。 重要的是要告诉你的医生关于所有其他药物的使用,包括维生素和草药。 不停止使用任何药物,没有第一个说你的医生。
医界专家:监测:Beta-2肾上腺素激动剂,可以造成的剂量相关的延长夸脱间隔和钾的损失。 从理论上讲,共同给予与其他药剂,可以延长的建间间隔可能会导致累加效应和风险增加的心律失常包括心动de扭转性和突然死亡。 在一般情况下,危险的个人的代理人或一组合剂,导致心律失常的协会与建延长很大程度上是不可预测,但可以通过增加某些基本风险因素,诸如先天性长夸脱综合症、心脏病、以及电解质紊乱(例如,低钾,镁血症). 此外,药物诱发的夸脱的延长取决于特定的药物(s)参与和剂量(s)的药物(s)。 临床显着延长夸脱间隔和低钾很少发生时beta-2兴奋剂吸入在通常建议的剂量。 然而,这些影响可能更常见的药物具有系统重要性时或推荐剂量超过。
管理:谨慎建议,如果beta-2激动剂结合使用其他药物,可以延长夸脱的时间间隔。 患者应建议寻求迅速的医疗注意,如果他们遇到的症状可能表明发生心动de扭转性,例如头晕、头晕、昏厥,心悸,不规则的心律、呼吸急促,或者昏厥。
- "Product Information. Arcapta Neohaler (indacaterol)." Novartis Pharmaceuticals, East Hanover, NJ.
- Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24
- Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9
- Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5
- "Product Information. Maxair (pirbuterol)." 3M Pharmaceuticals, St. Paul, MN.
- "Product Information. Brovana (arformoterol)." Sepracor Inc, Marlborough, MA.
- Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32
- Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7
- Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75
- Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5
- "Product Information. Xopenex (levalbuterol)." Sepracor, Marlborough, MA.
- Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71
- Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9
- Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20
- Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90
- "Product Information. Severent (salmeterol)." Glaxo Wellcome, Research Triangle Park, NC.
- Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9
- "Product Information. Proventil (albuterol)." Schering Laboratories, Kenilworth, NJ.
- "Product Information. Foradil (formoterol)" Novartis Pharmaceuticals, East Hanover, NJ.
- Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6
- Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9
- "Hypokalaemia due to salbutamol overdosage." Br Med J (Clin Res Ed) 283 (1981): 500-1
- Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6
- "Product Information. Striverdi Respimat (olodaterol)." Boehringer Ingelheim, Ridgefield, CT.
- Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61
- Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51
- Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9
- Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33
- Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9
- "Product Information. Breo Ellipta (fluticasone-vilanterol)." GlaxoSmithKline, Research Triangle Park, NC.
非专利名称: fluticasone / salmeterol
品牌: Advair Diskus, Advair HFA, AirDuo RespiClick, Wixela Inhub
同义词: Advair HFA
在药物相容性与互相作用的检测过程中使用下列的信息来源:Drugs.com, Rxlist.com, Webmd.com, Medscape.com。